Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Nakagawa

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Chembiochem : a European Journal of Chemical Biology|February 4, 2020
Paving the Way for Practical Use of Sugar-Binding Natural Products as Lectin Mimics in Glycobiological ResearchYu Nakagawa
Advances in Experimental Medicine and Biology|March 31, 2026
Carbohydrate-Binding Mechanism and Therapeutic Potential of Lectin MimicsYu Nakagawa
Bioscience, Biotechnology, and Biochemistry|July 13, 2012
Artificial analogs of naturally occurring tumor promoters as biochemical tools and therapeutic leadsYu Nakagawa
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|January 11, 2022
Mannose-binding analysis and biological application of pradimicinsYu Nakagawa, Yukishige Ito
Advances in Carbohydrate Chemistry and Biochemistry|December 11, 2012
Molecular architecture and therapeutic potential of lectin mimicsYu Nakagawa, Ito Yukishige
Chemical Record (New York, N.Y.)|July 26, 2005
Toward the development of new medicinal leads with selectivity for protein kinase C isozymesKazuhiro Irie, Yu Nakagawa, Hajime Ohigashi
Carbohydrate Research|June 18, 2026
Binding evaluation of poacic acid for fungal cell-wall glycans and β-1,3-glucooligosaccharidesKaho Chihara, Yoshiharu Sawada, Yu Nakagawa
Biochemistry|December 29, 2016
Solid-State Nuclear Magnetic Resonance Analysis Reveals a Possible Calcium Binding Site of Pradimicin ATakashi Doi, Yu Nakagawa, K Takegoshi
Current Pharmaceutical Design|May 12, 2004
Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymesKazuhiro Irie, Yu Nakagawa, Hajime Ohigashi
Medicinal Research Reviews|April 28, 2012
Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase CδKazuhiro Irie, Ryo C Yanagita, Yu Nakagawa
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Chembiochem : a European Journal of Chemical Biology|February 4, 2020
Paving the Way for Practical Use of Sugar-Binding Natural Products as Lectin Mimics in Glycobiological ResearchYu Nakagawa
Advances in Experimental Medicine and Biology|March 31, 2026
Carbohydrate-Binding Mechanism and Therapeutic Potential of Lectin MimicsYu Nakagawa
Bioscience, Biotechnology, and Biochemistry|July 13, 2012
Artificial analogs of naturally occurring tumor promoters as biochemical tools and therapeutic leadsYu Nakagawa
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|January 11, 2022
Mannose-binding analysis and biological application of pradimicinsYu Nakagawa, Yukishige Ito
Advances in Carbohydrate Chemistry and Biochemistry|December 11, 2012
Molecular architecture and therapeutic potential of lectin mimicsYu Nakagawa, Ito Yukishige
Chemical Record (New York, N.Y.)|July 26, 2005
Toward the development of new medicinal leads with selectivity for protein kinase C isozymesKazuhiro Irie, Yu Nakagawa, Hajime Ohigashi
Carbohydrate Research|June 18, 2026
Binding evaluation of poacic acid for fungal cell-wall glycans and β-1,3-glucooligosaccharidesKaho Chihara, Yoshiharu Sawada, Yu Nakagawa
Biochemistry|December 29, 2016
Solid-State Nuclear Magnetic Resonance Analysis Reveals a Possible Calcium Binding Site of Pradimicin ATakashi Doi, Yu Nakagawa, K Takegoshi
Current Pharmaceutical Design|May 12, 2004
Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymesKazuhiro Irie, Yu Nakagawa, Hajime Ohigashi
Medicinal Research Reviews|April 28, 2012
Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase CδKazuhiro Irie, Ryo C Yanagita, Yu Nakagawa
Pageof 5